MedTechGenie

[MedTechGenie @MedTechGenie]

On this Veterans Day we'd like to thank Capt. Jeremy Fresques.

https://t.co/jz8fRlzw1Z

[MedTechGenie @MedTechGenie]

Final LCDs for MIGS coverage by four MACs call into question coverage for certain procedures. #reimbursement #glaucoma

https://t.co/ZmaFMQcwiK

[MedTechGenie @MedTechGenie]

@DentsplySirona hosts their investor day with a goal to grow earnings at a 15% CAGR between 2023-2026 through streamlining and leveraging its digital assets for growth. #XRAY #investorday

https://t.co/l6Iy3ZBMxf

[MedTechGenie @MedTechGenie]

@QIAGEN launches new digital PCR tests for cell/gene therapy, DNA/RNA quantification, and food safety on its QIAcuity system. #QGEN #diagnostics

https://t.co/XcomKNigdc

[MedTechGenie @MedTechGenie]

@ExagenInc announces a new agreement with Johns Hopkins to license biomarkers for development of a lupus nephritis diagnostic test. #XGN #diagnostics #lupus

https://t.co/0RtMnS5Qg4

[MedTechGenie @MedTechGenie]

@AdaptiveBiotech announces a strategic review following disappointing 3Q23 results. #ADPT #earnings

https://t.co/WX69nkafnh

[MedTechGenie @MedTechGenie]

@Hologic posts solid 3Q23 results as microprocessor shortages drive a backlog in mammography systems and non-COVID-19 diagnostic growth remains strong. #HOLX #mammography #earnings

https://t.co/R8DqHPyBN6

[MedTechGenie @MedTechGenie]

@illumina posted a challenging 3Q23, but its post-GRAIL profitability could start to make it a target for value focused investors or acquirers. #ILMN #earnings #Genomics

https://t.co/h3A922SOS4

[MedTechGenie @MedTechGenie]

@Natera posted a strong 3Q23 and raised their full year outlook with a number of pending catalysts such as potential Medicare reimbursement for Renasight and continued growth of their leading MRD franchise. #NTRA #earnings #diagnostics #MRD

https://t.co/cnmHAFYGMT

[MedTechGenie @MedTechGenie]

@Invitae's loss increases and revenue declines in the 3Q23 increasing concerns around liquidity and the sustainability of the company. #NVTA #earnings #Genomics

https://t.co/8w7v1kA9sG

[MedTechGenie @MedTechGenie]

New data from ASTRO shows SBRT could be highly effective at treating localize kidney cancer. Positive for radiation therapy providers such as @Accuray. #ARAY #radiationtherapy #kidneycancer

https://t.co/9jnb6ELwfr

[MedTechGenie @MedTechGenie]

Oxford Nanopore has acquired Norther Nanopore Instruments to boost its solid state nanopore development program which could allow detection of multiple biological molecules such as DNA, RNA, metabolites, and proteins. #sequencing #lifescience #nanopore

https://t.co/WZUoaKN4YT

[MedTechGenie @MedTechGenie]

COMBINEDBrain has started a new study to expedite cures for neurodevelopmental disorders by providing whole genome sequencing (WGS) to infants displaying early symptoms of rare genetic neurodevelopmental disorders. #WGS #sequencing

https://t.co/ilxLcsRTpM

[MedTechGenie @MedTechGenie]

@owletmedical receives FDA approval for its wearable Dream Sock baby monitor without a prescription opening it back up to the market following a previous FDA warning letter. #OWLT #wearables #pediatrics

https://t.co/a9WtbrI3jL

[MedTechGenie @MedTechGenie]

@23andMe revenue declines and losses increase in 3Q23 - management is trying to increase price/breadth of service offerings and reduce cost to reduce cash burn but the business is heavily dependent on DTC advertising. #ME #earnings #consumergenetics

https://t.co/JMnN0dDHAd

[MedTechGenie @MedTechGenie]

@ultromics has received a HOPPS code for its heart failure detection technology following IPPS reimbursement earlier this year. Likely to drive increased adoption. #heartfailure #reimbursement

https://t.co/CfnKWmMlJj

[MedTechGenie @MedTechGenie]

@neuronetics magnetic stimulation therapy for depression saw a bunch of payers lower the number of medication failures before coverage is approved. #STIM #depression #reimbursement

https://t.co/QhOLlmdfT2

[MedTechGenie @MedTechGenie]

Medicare has crosswalked the code for Aspira Womens' Health new OvaWatch test to the old code ensuring continuity of reimbursement. #AWH #ovariancancer

https://t.co/0Bxhngw7RV

[MedTechGenie @MedTechGenie]

@orasure beats estimates in the 3Q23, investors are looking for the next act after the company's InteliSwab COVID-19 test to drive growth. #OSUR #COVID19 #earnings

https://t.co/lJQWPDXu0N

[MedTechGenie @MedTechGenie]

@AdaptiveBiotech announces a new MRD partnership with leukemia drug maker Beigene for its clonoSEQ assay for MRD assessment in bone marrow. #ADPT #MRD #leukemia

https://t.co/5TETvMNnNH